Ultrasound can reveal physical signs that raise the likelihood a baby has Down syndrome, but it cannot diagnose the condition on its own. What an ultrasound does is flag features, sometimes called “markers,” that occur more frequently in fetuses with trisomy 21 than in those without it. Some markers are subtle and easy to miss; others, like certain heart defects, are more conspicuous. The accuracy of ultrasound as a screening tool depends heavily on what is being measured, when during pregnancy the scan takes place, and whether the ultrasound findings are combined with blood tests or newer genetic screens.
What Happens in the First Trimester
The earliest ultrasound marker for Down syndrome is a measurement called nuchal translucency, taken between roughly 11 and 14 weeks of pregnancy. This is the fluid-filled space at the back of the baby’s neck. A larger-than-expected pocket of fluid suggests a higher risk of chromosomal conditions, including trisomy 21. A meta-analysis pooling data from over 225,000 low-risk pregnancies found that nuchal translucency alone picked up about 68% of Down syndrome cases, with a specificity around 96%, meaning most unaffected pregnancies were correctly identified as low risk.1PubMed Central. The Diagnostic Performance of Nuchal Translucency Alone as a Screening Test for Down Syndrome: A Systematic Review and Meta-analysis In an earlier single-center study, using a cutoff of 3 mm or more identified about two-thirds of affected fetuses, with only about 2% of all women sent for invasive testing.2PubMed. Screening for Down’s syndrome by fetal nuchal translucency measurement in a general obstetric population
Another first-trimester marker is the fetal nasal bone. In many fetuses with Down syndrome, the nasal bone is absent or unusually short at this stage. One study found the nasal bone was absent in about two-thirds of Down syndrome cases at 11 to 14 weeks, compared with only 1% of unaffected fetuses.3PubMed. Measurement of nasal bone length at 11-14 weeks of pregnancy and its potential role in Down syndrome risk assessment A smaller study found similar patterns, with an absent nasal bone in three of five fetuses with trisomy 21 and in fewer than 1% of chromosomally normal fetuses.4PubMed. Association between first trimester absence of fetal nasal bone on ultrasound and Down syndrome The nasal bone check is useful, but it works best when folded into a broader assessment rather than used in isolation.
Why Combining Ultrasound with Blood Tests Matters
Nuchal translucency or nasal bone assessment alone catches a meaningful share of affected pregnancies, but combining ultrasound with maternal blood markers pushes detection rates considerably higher. When nuchal translucency is paired with two blood proteins measured in the first trimester and additional blood markers from the second trimester, the combined approach detects roughly nine out of ten Down syndrome pregnancies at a 5% false-positive rate.5Cochrane Database of Systematic Reviews. Screening for Down’s syndrome using first and second trimester serum markers with or without first trimester ultrasound markers A separate Cochrane review confirmed that combining nuchal translucency with first-trimester serum markers and maternal age significantly outperformed ultrasound markers alone.6Cochrane Database of Systematic Reviews. First trimester ultrasound alone or in combination with first trimester serum tests for the prediction of Down syndrome risk
Modeling from one study suggested that adding nasal bone assessment to nuchal translucency plus blood markers could push detection to around 95% with a false-positive rate under 3%.3PubMed. Measurement of nasal bone length at 11-14 weeks of pregnancy and its potential role in Down syndrome risk assessment The large FASTER trial in the United States explored several permutations of first- and second-trimester screening strategies, including stepwise sequential approaches where results are provided after each round and fully integrated approaches where a single risk figure is delivered after all tests are complete.7PubMed. First-trimester or second-trimester screening, or both, for Down’s syndrome The general principle across all these strategies is the same: ultrasound alone is informative, but pairing it with biochemistry gives a much clearer picture.
Second-Trimester Soft Markers
If you’ve heard the phrase “soft marker” from your OB after a mid-pregnancy ultrasound, it refers to minor anatomical variations that are slightly more common in fetuses with Down syndrome but also appear in a significant number of perfectly healthy babies. The main ones include a thickened nuchal fold (measured later than the first-trimester nuchal translucency), short upper-arm bone (humerus), short thigh bone (femur), an echogenic intracardiac focus (a bright spot in the heart), echogenic bowel, and mild kidney dilation.8PubMed. The role of the second trimester genetic sonogram in screening for fetal Down syndrome
These markers vary widely in how strongly they point toward Down syndrome. A thickened nuchal fold in the second trimester was found to be the single most discriminating soft marker, associated with roughly a 17-fold increased risk. But for most other individual markers observed without accompanying structural abnormalities, the impact on risk was marginal.9JAMA. Second-Trimester Ultrasound to Detect Fetuses With Down Syndrome: A Meta-analysis
An echogenic intracardiac focus, for example, shows up in roughly 5% of all fetuses. A meta-analysis found its sensitivity for Down syndrome was only about 22%, meaning it misses the vast majority of affected pregnancies, though when present it does raise the odds modestly.10PubMed. Meta-analysis of validity of echogenic intracardiac foci for calculating the risk of Down syndrome in the second trimester of pregnancy Short long bones tell a similar story. One study found that about a quarter of fetuses with Down syndrome had a short humerus and a quarter had a short femur, but having both carried an 11-fold increased risk.11PubMed. Humerus and femur length shortening in the detection of Down’s syndrome Interestingly, the humerus seems to be a somewhat better individual indicator than the femur: in one study, a short humerus caught about 64% of trisomy 21 cases, while a short femur caught only 18%.12American Journal of Obstetrics and Gynecology. Comparison of humerus length with femur length in fetuses with Down syndrome
One large study found that common isolated soft markers like choroid plexus cysts, echogenic bowel, mild kidney dilation, and short limb bones, when observed without any structural anomaly, were not individually associated with Down syndrome in a statistically meaningful way.13PubMed. Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of Down syndrome That finding is worth keeping in mind: a single isolated soft marker in an otherwise normal scan is usually not a reason to panic.
Structural Abnormalities That Raise Stronger Suspicion
Beyond soft markers, some fetuses with Down syndrome have structural birth defects visible on ultrasound, and these carry more diagnostic weight. Heart defects are the most common. In one large study of nearly 500 Down syndrome pregnancies, about a third had a structural heart defect, with the most common being an atrioventricular septal defect, a hole between the upper and lower chambers of the heart.14PubMed. Prenatally detectable congenital heart defects in fetuses with Down syndrome A Norwegian cohort study confirmed that atrioventricular septal defects were the most frequent heart anomaly in Down syndrome, accounting for over 44% of heart defects in that group.15PubMed Central. Down syndrome and associated atrioventricular septal defects in a nationwide Norwegian cohort: Prevalence, time trends, and outcomes
Another structural finding linked to Down syndrome is duodenal atresia, a blockage of the first part of the small intestine. On ultrasound, this produces a distinctive “double bubble” sign: two dark circles in the fetal abdomen representing the distended stomach and the blocked duodenum. In one case series, about a third of fetuses showing this sign had trisomy 21.16PubMed Central. The Double Bubble Sign: Duodenal Atresia and Associated Genetic Etiologies The double bubble sign typically appears later in pregnancy, sometimes not until the third trimester.17PubMed Central. Imaging the Double Bubble: A Case of Duodenal Atresia Detected in Late Pregnancy When a sonographer spots either a heart defect or a double bubble, the conversation about genetic testing usually becomes more urgent.
How Cell-Free DNA Screening Has Changed the Picture
The arrival of cell-free DNA screening, sometimes called noninvasive prenatal testing or NIPT, has reshaped the way ultrasound findings are interpreted. This blood test analyzes fragments of fetal DNA circulating in the mother’s bloodstream and is highly accurate for detecting trisomy 21, with detection rates well above 99% in most studies. Because NIPT is so sensitive, it has changed the clinical significance of soft markers on ultrasound.
Current expert guidance suggests that if a woman has already received a negative cell-free DNA screen, a nuchal translucency measurement at 11 to 14 weeks should not be performed solely for Down syndrome screening, and isolated soft markers in the second trimester should not, on their own, prompt invasive diagnostic testing like amniocentesis.18American Journal of Obstetrics & Gynecology. The role of ultrasound in women who undergo cell-free DNA screening In practice, this means that if you had NIPT and it came back low risk, and then your 20-week anatomy scan shows a single bright spot in the heart or mildly short femur and nothing else, your doctor will likely tell you the finding is not clinically significant.
That said, soft markers have not been retired entirely. They can still flag cases that cell-free DNA missed (rare, but it happens), and some soft markers are associated with conditions beyond Down syndrome that NIPT does not screen for.19PubMed Central. Second trimester soft markers: still worth to be mentioned? And for women who did not have NIPT or first-trimester screening, the second-trimester anatomy scan remains an important screening opportunity.
Why Maternal Weight Affects What Ultrasound Can See
One factor that rarely gets discussed in patient-facing material is how maternal body size affects the reliability of ultrasound screening. Adipose tissue absorbs and scatters ultrasound waves, making it harder to get clear images. The consequences are real and measurable. In one study, the completion rate for a full soft-marker evaluation dropped from 64% in women of normal weight to just 47% in women with a BMI above 40.20PubMed. Ultrasound screening for fetal aneuploidy using soft markers in the overweight and obese gravida If markers can’t be seen, they can’t be counted.
The downstream effect is that obese women are effectively underscreened by ultrasound. Data from the FASTER trial showed that the sensitivity for detecting multiple aneuploidy markers dropped from about 32% in women with a BMI under 25 to about 22% in those with a BMI over 30. Detection of cardiac anomalies also fell sharply.21PubMed. Influence of maternal BMI on genetic sonography in the FaSTER trial Another study concluded that in obese women who do complete a full anatomic ultrasound, the absence of soft markers is simply less reassuring than it would be in a thinner patient, because adequate visualization is more limited.22PubMed Central. Limitations of Aneuploidy and Anomaly Detection in the Obese Patient This is one of the stronger arguments for NIPT in higher-BMI pregnancies: the blood test doesn’t care about tissue depth.
Operator Skill and Equipment Quality
Ultrasound is inherently operator-dependent. Two sonographers scanning the same fetus can produce meaningfully different assessments, especially for subtle measurements like nuchal translucency thickness or nasal bone presence. A key limitation of ultrasound screening is the substantial absence of fully standardized quantitative parameters and the heavy reliance on the experience of the person holding the probe.23PubMed Central. Sonographic markers for early diagnosis of fetal malformations Fetal position, gestational age, and image resolution all play a role too. In research settings with trained specialists and high-end equipment, detection rates tend to be higher than what an average community clinic achieves. If you’re at a smaller practice and a screening result is ambiguous, asking for a referral to a maternal-fetal medicine specialist for a targeted ultrasound is a reasonable step.
The Frontomaxillary Facial Angle
Researchers have explored more exotic ultrasound measurements in an effort to improve detection. One of the more studied is the frontomaxillary facial angle, which measures the angle between the forehead and the upper jaw. In fetuses with Down syndrome, the face tends to be flatter, producing a wider angle. One study found the angle was above 85 degrees in about 69% of trisomy 21 fetuses versus only 5% of unaffected ones during the first trimester.24American Journal of Obstetrics & Gynecology. The frontomaxillary facial angle in fetuses with trisomy 21 at 11–13 weeks of gestation In the second trimester, about 65% of affected fetuses had an angle above the 95th percentile.25PubMed. Frontomaxillary facial angle in trisomy 21 fetuses at 16-24 weeks of gestation
This sounds promising, but the measurement has practical problems. It is technically difficult to obtain consistently, and the normal range appears to vary by ethnicity. A study comparing Caucasian and Asian populations found significantly different baseline measurements, suggesting that ethnic-specific reference ranges would be needed before the angle could be used in routine screening.26PubMed Central. The Effect of Ethnicity on 2D and 3D Frontomaxillary Facial Angle Measurement in the First Trimester For now, the frontomaxillary facial angle remains a research tool rather than a standard part of clinical practice.
Twin Pregnancies
Screening for Down syndrome in twins presents a unique challenge. In a twin pregnancy where one fetus is affected and the other is not, the usual ultrasound ratios that compare bone measurements to head size did not reliably distinguish the affected twin from the healthy one.27PubMed. Ultrasound detection of Down syndrome: is it really possible? The most informative marker in that setting was a thickened nuchal fold, the same marker that performs best in singleton pregnancies. Cell-free DNA screening also becomes trickier in twins because the fetal DNA contribution from each twin varies, and the test may not be able to attribute a positive signal to a specific twin. For dichorionic twins, NIPT performance is reasonably good but still slightly less accurate than in singletons; for monochorionic twins, the issue is less relevant since both share the same genetic material.
What an Ultrasound Finding Actually Means for You
Understanding the difference between screening and diagnosis is essential here. Ultrasound, whether alone or combined with blood work, is a screening tool. It adjusts the probability that the baby has Down syndrome, but it does not confirm or rule it out with certainty. A definitive answer requires invasive testing: chorionic villus sampling in the first trimester or amniocentesis in the second, both of which analyze fetal chromosomes directly.
The emotional weight of hearing about a soft marker can be significant. Research has found that women told about a soft ultrasound finding experience anxiety levels comparable to those of women with abnormal blood screening results, and both groups are substantially more anxious than women whose only risk factor is age.28PubMed. Anxiety and prenatal testing: do women with soft ultrasound findings have increased anxiety compared to women with other indications for testing? How the finding is communicated matters. Qualitative research has shown that the clinician’s manner and the emotional framing of the conversation influence how parents perceive and cope with the information.29PubMed Central. Clinician communication after discovery of a soft marker of aneuploidy during pregnancy: A mixed methods assessment of a communication workshop If you’ve been told about a marker and feel overwhelmed, asking for a genetic counseling appointment is a concrete next step that can help you interpret what the finding actually means for your specific risk profile.
How Screening Has Evolved Over Time
The use of ultrasound to screen for Down syndrome is a relatively recent development. The first recognized second-trimester marker, nuchal fold thickening, was described in 1985. Over the following decade, researchers identified a cluster of additional soft markers, and by the 1990s these were being combined into what clinicians call a “genetic sonogram,” a targeted ultrasound that systematically evaluates multiple markers during the anatomy scan.30PubMed. The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice The addition of first-trimester screening with nuchal translucency and blood markers in the early 2000s moved the screening window earlier, giving families more time to make decisions. And now, with NIPT widely available, the role of ultrasound is shifting from primary screener toward a complementary tool that confirms, supplements, or occasionally catches what other methods miss.
None of these advances has made ultrasound obsolete. Even when NIPT is negative, the anatomy scan at 18 to 22 weeks remains critical for identifying structural issues like heart defects and bowel obstructions that can occur with or without Down syndrome. These findings affect delivery planning, neonatal care, and surgical preparation regardless of the chromosomal diagnosis. The scan has always done double duty, and that part of its job is not going anywhere.